We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 280 results
  1. Preclinical efficacy of cannabidiol for the treatment of early-life seizures

    Background

    The treatment of epilepsy during early life poses unique challenges—first-line therapies leave many individuals with poorly controlled...

    Eric Witherspoon, Sean Quinlan, Patrick A. Forcelli in Pharmacological Reports
    Article 12 October 2022
  2. Molecular insights into the therapeutic promise of targeting HMGB1 in depression

    Depression is a common psychiatric disorder, the exact pathogenesis of which is still elusive. Studies have proposed that immunity disproportion and...

    Tarapati Rana, Tapan Behl, ... Simona Bungau in Pharmacological Reports
    Article 04 October 2020
  3. Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder

    While the ICH E9(R1) Addendum on “Estimands and Sensitivity Analysis in Clinical Trials” was released in late 2019, the widespread implementation of...

    Elena Polverejan, Michael O’Kelly, ... Marc K. Walton in Therapeutic Innovation & Regulatory Science
    Article Open access 27 May 2023
  4. Voltammetric Determination of Diphenhydramine Hydrochloride in Solid and Liquid Dosage Forms

    A method for accelerated determination of diphenhydramine hydrochloride (dimedrol, DPH) in liquid and solid dosage forms (DFs) that is based on...

    E. V. Turusova, O. E. Nasakin in Pharmaceutical Chemistry Journal
    Article 18 March 2023
  5. Consider cannabinoids as an individual therapeutic trial in nociplastic pain

    Nociplastic pain, which is characterized by widespread chronic pain and a range of central nervous system and other somatic symptoms, is associated...

    Esther S. Kim, Connie Kang in Drugs & Therapy Perspectives
    Article 22 November 2022
  6. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions

    Thyroid hormones (THs) play an important role in the regulation of energy metabolism. They also take part in processes associated with the central...

    Nadia Sawicka-Gutaj, Natalia Zawalna, ... Marek Ruchała in Pharmacological Reports
    Article 30 June 2022
  7. Effects and mechanisms of phthalates’ action on neurological processes and neural health: a literature review

    During the period of mass industrial production of plastic products, the quality of human health has decreased significantly, especially in...

    Henrieta Hlisníková, Ida Petrovičová, ... Alexander Sirotkin in Pharmacological Reports
    Article 18 January 2021
  8. Preclinical models of treatment-resistant depression: challenges and perspectives

    Treatment-resistant depression (TRD) is a subgroup of major depressive disorder in which the use of classical antidepressant treatments fails to...

    Magdalena Kolasa, Agata Faron-Górecka in Pharmacological Reports
    Article Open access 26 October 2023
  9. Potential drugs for the treatment of Alzheimer’s disease

    It is well known that amyloid precursor protein (APP), the enzyme β-secretase 1 (BACE1), cyclooxygenase 2 (COX-2), nicastrin (NCT), and...

    Tania Guadalupe Montero-Cosme, Luz Irene Pascual-Mathey, ... Gonzalo Emiliano Aranda-Abreu in Pharmacological Reports
    Article 01 April 2023
  10. Manage antipsychotic-induced akathisia by making changes to the antipsychotic drug regimen and/or adding anti-akathisia agents

    Antipsychotic-induced akathisia (AIA) is a common and distressing adverse effect associated with many first- and second-generation antipsychotics....

    Esther S. Kim, Young-A Heo in Drugs & Therapy Perspectives
    Article 18 December 2020
  11. Deprescribing

    Deprescribing refers to reducing or stop** medications that may no longer be needed, may be causing more harm than good, or may not align with a...
    Reference work entry 2023
  12. Presynaptic antiseizure medications - basic mechanisms and clues for their rational combinations

    Among clinically highly efficient antiseizure medications (ASMs) there are modifiers of the presynaptic release machinery. Of them, levetiracetam and...

    Ewa K. Czapińska-Ciepiela, Jarogniew Łuszczki, ... Władysław Lasoń in Pharmacological Reports
    Article Open access 22 May 2024
  13. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists

    Over the last decade, new psychoactive substances (NPS) have continuously been the focus of the international society since their emergence on the...

    Eun Yong Chung, Hye ** Cha, ... Jaesuk Yun in Archives of Pharmacal Research
    Article 02 April 2021
  14. Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis

    Diabetes mellitus (DM) is a metabolic disease that activates several molecular pathways involved in neurodegenerative disorders. Metformin, an...

    Fatemeh Karami, Hamidreza Jamaati, ... Majid Motaghinejad in Pharmacological Reports
    Article 24 April 2023
  15. Targeting the CCL2-CCR2 axis in depressive disorders

    Since affective disorders are considered to be underlain by the immune system malfunction, an important role in their pathophysiology is assigned to...

    Katarzyna Curzytek, Monika Leśkiewicz in Pharmacological Reports
    Article Open access 24 May 2021
  16. Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited

    There is a growing interest in the use of cannabis for medical purposes, especially in older patients who experience pain, sleep difficulties, mood...

    Article 23 July 2019
  17. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

    Background

    Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of...

    Joanna Kryst, Paweł Kawalec, ... Tomasz Brzostek in Pharmacological Reports
    Article Open access 16 April 2020
  18. Synthesis and anticonvulsant screening of 1,2,4-triazole derivatives

    Background

    Currently available antiepileptic drugs offer limited symptomatic treatment and fail to cure more than 30% of the epileptic seizures....

    Suat Sari, F. Betül Kaynak, Sevim Dalkara in Pharmacological Reports
    Article 23 June 2018
  19. Frequency and nature of potential drug–drug interaction in medical wards: a cross-sectional study in a teaching hospital

    Background

    The safety and proper utilization of a drug depends not only on its pharmacological action, but also its interactions with other drugs and...

    Tariq Khan, Khayal Muhammad, ... Nisar Ur Rehman in Drugs & Therapy Perspectives
    Article 25 February 2020
  20. A critical review of pyritinol

    Pyritinol (pyrithioxine) is a combination of two molecules of vitamin B 6 (pyridoxine) with disulfide linkage. Its pharmacokinetic profile mimics that...

    Alok Singh, Vinay Purohit in Drugs & Therapy Perspectives
    Article 01 April 2019
Did you find what you were looking for? Share feedback.